# Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)

> **NCT04188262** · PHASE1 · COMPLETED · sponsor: **Alucent Biomedical** · enrollment: 9 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Catheterization, Peripheral

## Interventions

- **COMBINATION_PRODUCT:** NVS Therapy

## Key facts

- **NCT ID:** NCT04188262
- **Lead sponsor:** Alucent Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-22
- **Primary completion:** 2022-04-05
- **Final completion:** 2022-05-31
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04188262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04188262, "Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04188262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*